Oligodendrocytes, BK channels and remyelination (2021)
Attributed to:
Biomedical Catalyst – Drug product production, clinical support studies, and phase 1 trial of a new MS drug
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.12688/f1000research.53422.1
Publication URI: http://dx.doi.org/10.12688/f1000research.53422.1
Type: Journal Article/Review
Parent Publication: F1000Research